08:42 AM EDT, 06/06/2024 (MT Newswires) -- Cytek Biosciences ( CTKB ) said Thursday that its board has approved up to an aggregate of $50 million share buyback plan, effective until Dec. 31.
The company's shares were up 3.7% in recent Thursday premarket activity.
Price: 5.94, Change: +0.21, Percent Change: +3.66